Long-term outcomes of highly experienced people with HIV undergoing salvage therapy with raltegravir

Raltegravir and other third-line drugs have shown promise in improving outcomes in treatment-experienced patients. However, the efficacy and tolerability of these agents vary. This study assessed real-life virologic success, long-term survival, and adverse events in patients receiving raltegravir or...

Descripción completa

Detalles Bibliográficos
Autores principales: Patiño Escarcina, Jesús Enrique, Netto, Eduardo Martins, Brites, Carlos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
4900
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10553021/
https://www.ncbi.nlm.nih.gov/pubmed/37800823
http://dx.doi.org/10.1097/MD.0000000000035407

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10553021/
https://www.ncbi.nlm.nih.gov/pubmed/37800823
http://dx.doi.org/10.1097/MD.0000000000035407

Ejemplares similares